Published in J Nutr on June 27, 2012
Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia. | NCT02863822
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.87
Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol (2013) 1.24
Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes (2014) 1.19
Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver (2015) 1.18
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07
Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol (2016) 1.04
Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients (2015) 1.04
Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil (2015) 1.04
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97
Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94
Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther (2015) 0.92
The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil (2015) 0.91
Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) (2014) 0.91
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med (2016) 0.86
Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients (2015) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
The gastrointestinal tract microbiome, probiotics, and mood. Inflammopharmacology (2014) 0.84
Irritable bowel syndrome and food interaction. World J Gastroenterol (2014) 0.82
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol (2016) 0.82
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol (2014) 0.82
Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment Pharmacol Ther (2016) 0.80
The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clin Transl Gastroenterol (2015) 0.79
Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol (2016) 0.79
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol (2016) 0.78
Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol (2016) 0.78
The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients (2017) 0.78
Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial. Middle East J Dig Dis (2015) 0.77
Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study. BMC Gastroenterol (2015) 0.76
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Gluten free diet is a cure not a poison! Gastroenterol Hepatol Bed Bench (2015) 0.75
Staple foods consumption and irritable bowel syndrome in Japanese adults: a cross-sectional study. PLoS One (2015) 0.75
Restriction of FODMAP in the management of bloating in irritable bowel syndrome. Singapore Med J (2016) 0.75
Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol (2016) 0.75
Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75
Low FODMAP diet. Can Fam Physician (2015) 0.75
Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol (2017) 0.75
Irritable bowel syndrome and chronic constipation: Fact and fiction. World J Gastroenterol (2015) 0.75
Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes (2016) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome. Adv Nutr (2017) 0.75
Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function. J Clin Gastroenterol (2016) 0.75
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J (2017) 0.75
New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench (2017) 0.75
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients (2017) 0.75
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology (2013) 4.52
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol (2008) 3.33
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther (2008) 2.17
Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis (2010) 1.48
Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol (2008) 1.44
Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS One (2013) 1.28
Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr (2010) 1.27
Pathogenesis of colonic diverticulosis: repainting the picture. Clin Gastroenterol Hepatol (2013) 1.24
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis (2011) 1.22
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc (2007) 1.20
Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol (2006) 1.18
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis (2008) 1.18
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.05
Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut (2011) 1.05
Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem (2007) 1.03
Nutritional problems in inflammatory bowel disease: the patient perspective. J Crohns Colitis (2011) 1.01
Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem (2009) 0.99
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Not all effects of a gluten-free diet are due to removal of gluten. Gastroenterology (2013) 0.98
The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis (2009) 0.97
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol (2011) 0.96
A new family of H3 receptor antagonists based on the natural product Conessine. Bioorg Med Chem Lett (2007) 0.96
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2014) 0.95
Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis (2006) 0.95
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol (2010) 0.95
Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol (2010) 0.94
The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition (2010) 0.92
Distinguishing orofacial granulomatosis from crohn's disease: two separate disease entities? Inflamm Bowel Dis (2011) 0.92
Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol (2011) 0.92
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. J Crohns Colitis (2012) 0.92
Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. J Clin Invest (2015) 0.91
Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics. Eur J Gastroenterol Hepatol (2006) 0.90
Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis (2014) 0.90
Comparison of complications attributable to enteral and parenteral nutrition in predicted severe acute pancreatitis: a systematic review and meta-analysis. Br J Nutr (2010) 0.90
Top dietary iron sources in the UK. Br J Gen Pract (2014) 0.89
"Diversion" colitis caused by Clostridium difficile infection: report of a case. Dis Colon Rectum (2006) 0.88
Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune disease. Bioorg Med Chem Lett (2012) 0.87
Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.87
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis (2007) 0.84
Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.83
Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cells. J Immunol (2013) 0.83
Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open (2013) 0.83
Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study. Clin Nutr (2006) 0.83
Hospital inpatients' experiences of access to food: a qualitative interview and observational study. Health Expect (2008) 0.83
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis. Eur J Gastroenterol Hepatol (2012) 0.83
Semiquantitative assessment of breath hydrogen testing. J Gastroenterol Hepatol (2013) 0.82
Etiology of perianal Crohn's disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis (2009) 0.82
Alopecia areata: a possible extraintestinal manifestation of Crohn's disease. J Crohns Colitis (2013) 0.82
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease. Inflamm Bowel Dis (2015) 0.81
Is gluten a cause of gastrointestinal symptoms in people without celiac disease? Curr Allergy Asthma Rep (2013) 0.79
Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6 months of oral anticoagulation with warfarin. Blood Coagul Fibrinolysis (2009) 0.79
Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum (2014) 0.79
The application of genetics and nutritional genomics in practice: an international survey of knowledge, involvement and confidence among dietitians in the US, Australia and the UK. Genes Nutr (2013) 0.79
Experiences of food access in hospital. A new questionnaire measure. Clin Nutr (2009) 0.78
A preliminary qualitative exploration of dietitians' engagement with genetics and nutritional genomics: perspectives from international leaders. J Allied Health (2014) 0.78
Diet-induced models of obesity (DIO) in rodents. Curr Protoc Neurosci (2012) 0.77
Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat. Psychopharmacology (Berl) (2014) 0.77
Definitions, attitudes, and management practices in relation to diarrhea during enteral nutrition: a survey of patients, nurses, and dietitians. Nutr Clin Pract (2012) 0.77
Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia. J Med Chem (2010) 0.77
Other Dietary Confounders: FODMAPS et al. Dig Dis (2015) 0.77
Non-nutritional effects of food: an underutilized and understudied therapeutic tool in chronic gastrointestinal diseases. J Gastroenterol Hepatol (2013) 0.76
Optimizing conventional therapies for inflammatory bowel disease. Curr Gastroenterol Rep (2009) 0.76
A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. BMC Gastroenterol (2014) 0.76
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation. Bioorg Med Chem Lett (2009) 0.76
Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol (2015) 0.76
National UK audits in inflammatory bowel disease (IBD) highlight a deficit of dietitians in gastroenterology: a priority for improvement supported by national IBD standards. J Hum Nutr Diet (2009) 0.75
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? J Gastroenterol Hepatol (2009) 0.75
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y) (2008) 0.75
Diverticular disease of the colon. Lancet (2004) 0.75
Diarrhea during enteral nutrition-appropriate outcome measurement. Nutrition (2002) 0.75
Infliximab: getting the most for your money. J Gastroenterol Hepatol (2007) 0.75
Response to Comment on low FODMAP diet. Nutr Clin Pract (2013) 0.75
Leukocytapheresis in ulcerative colitis. Am J Gastroenterol (2006) 0.75
The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proc Nutr Soc (2017) 0.75
Knowledge and skills to encourage comprehensive research involvement among dietitians. J Hum Nutr Diet (2007) 0.75
Programmatic Assessment of Competence in Dietetics: A New Frontier. J Acad Nutr Diet (2016) 0.75
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomnia. J Med Chem (2010) 0.75
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis (2016) 0.75
Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia. Bioorg Med Chem Lett (2012) 0.75
Assessment of the Turkish Version of the King's Stool Chart for Evaluating Stool Output and Diarrhea Among Patients Receiving Enteral Nutrition. Gastroenterol Nurs (2015) 0.75
Designing a national clinical audit of nutritional care in health and social care settings: consideration and future directions. Proc Nutr Soc (2013) 0.75
Modification of the gastrointestinal microbiota and its application to clinical nutrition. J Hum Nutr Diet (2012) 0.75
Irritable bowel syndrome and diet: where are we in 2018? Curr Opin Clin Nutr Metab Care (2017) 0.75
Distinct management issues with Crohn's disease of the small intestine. Curr Opin Gastroenterol (2015) 0.75
Fructan content of commonly consumed wheat, rye and gluten-free breads. Int J Food Sci Nutr (2011) 0.75
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease. Inflamm Bowel Dis (2017) 0.75